Viral infection risk in polytransfused adults: Seroprevalence of seven viruses in central Tunisia;Le risque infectieux viral chez le polytransfusé: Séroprévalence de sept agents viraux dans le centre tunisien

Bulletin de la Societe de Pathologie Exotique

Volumn 104, Issue 3, 2011, Pages 220-225

  Hannachi, N ^a   Boughammoura, L ^a   Marzouk, M ^a   Tfifha, M ^a   Khlif, A ^a   Soussi, S ^a   Skouri, H ^b   Boukadida, J ^a  

^a FARHAT HACHED HOSPITAL   (Tunisia)

^b SAHLOUL UNIVERSITY HOSPITAL   (Tunisia)

Author keywords

Blood donor; Children; Maghreb; Northern Africa; Polytransfused; Tunisia; Virus

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; BLOOD DONOR; BLOOD TRANSFUSION; CHILD; DISEASE TRANSMISSION; EPIDEMIOLOGY; FEMALE; HERPES VIRUS INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PARVOVIRUS B19; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; INFANT; MALE; MIDDLE AGED; PARVOVIRUS INFECTION; PRESCHOOL CHILD; RISK; TUNISIA; VIRUS HEPATITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; BLOOD DONORS; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS, VIRAL, HUMAN; HERPESVIRIDAE INFECTIONS; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; RISK; SEROEPIDEMIOLOGIC STUDIES; TUNISIA; YOUNG ADULT;

EID: 80052453006     PISSN: 00379085     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13149-010-0103-7     Document Type: Article

References (30)

1. Allain JP, Stramer SL, Carneiro-Proietti AB, et al (2009) Transfusion-transmitted infectious diseases. Biologicals 37(2):71-7 (Epub 2009 Feb 20)
2. Ben Halima M, Arrouji Z, Slim A, et al (1998) Épidémiologie de l'hépatite E en Tunisie. Tunis Med 76(5):129-33
3. Ben Othman S, Bouzgarrou N, Achour A, et al (2004) Prévalence et incidence élevées de l'infection par le virus de l'hépatite C chez les hémodialysés dans la région Centre-Est de la Tunisie. Pathol Biol 52(6):323-7 (Pubitemid 38916891)
4. Calderón GM, González-Velázquez F, González-Bonilla CR, et al (2009) Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico. Transfusion 49(10):2200-7 (Epub 2009 Jun 15)
5. Candotti D, Allain JP (2009) Transfusion-transmitted hepatitis B virus infection. J Hepatol 51(4):798-809 (Epub 2009 Jun 10)
6. Candotti D, Sarkodie F, Allain JP (2001) Residual risk of transfusion in Ghana. Br J Haematol 113(1):37-9 (Pubitemid 32423298)
7. Cannon MJ, Operskalski EA, Mosley JW, et al (2009) Lack of evidence for human herpesvirus 8 transmission via blood transfusion in a historical US cohort. J Infect Dis, 199(11):1592-8
8. Challine D, Roudot-Thoraval F, Sarah T, et al (2001) Seroprevalence of human herpesvirus 8 antibody in populations at high or low risk of transfusion, graft, or sexual transmission of viruses. Transfusion 41(9):1120-5 (Pubitemid 32848088)
9. Coste J (2000) Le dépistage de génomes viraux en transfusion sanguine. Transfus Clin Biol 7:11s-7s
10. Cottoni F, Santarelli R, Gentile G, et al (2004) High rate of human herpesvirus 8 seroprevalence in thalassemic patients in Italy. J Clin Virol 30(1)106-9 (Pubitemid 38457077)
11. Dodd R, Kurt Roth W, Ashford P et al (2009) Transfusion medicine and safety. Biologicals 37(2):62-70 (Epub 2009 Feb 20)
12. Dollard SC, Nelson KE, Ness PM, et al (2005) Possible transmission of human herpesvirus 8 by blood transfusion in a historical United States cohort. Transfusion 45(4):500-3
13. Dzik S, Aubuchon J, Jeffries L, et al (2000) Leukocyte reduction of blood components: public policy and new technology. Transfus Med Rev 14(1):34-52 (Pubitemid 30055947)
14. Gargouri J, Elleuch H, Karray H, et al (2000) Prevalence of anti- CMV antibodies in blood donors in the Sfax region (value in blood transfusion). Tunis Med 78(8-9):512-7
15. Guertler L (2002) Virus safety of human blood, plasma, and derived products. Thromb Res 107(Suppl 1):S39-S45
16. Hannachi N, Hidar S, Harrabi I, et al (2010) Séroprévalence et facteurs de risque de l'hépatite virale E chez la femme enceinte dans le centre tunisien. Pathol Biol (Paris) (in press)
17. Hladik W, Dollard SC, Mermin J, et al (2006) Transmission of human herpesvirus 8 by blood transfusion. N Engl J Med 355(13):1331-8 (Pubitemid 44465461)
18. Hmaied F, Ben Mamou M, Saune-Sandres K, et al (2006) Hepatitis C virus infection among dialysis patients in Tunisia: incidence and molecular evidence for nosocomial transmission. J Med Virol 78(2):185-91 (Pubitemid 43132562)
19. Jlizi A, Azzouzi A, Bouzayen I, et al (2009) Effets de l'exposition prolongée au traitement chez des patients tunisiens, évalué s par le test génotypique de résistance du VIH-1. Med Mal Infect 39(9):707-13 (Epub 2008 novembre 22)
20. Khuroo MS, Kamili S, Yattoo GN (2004) Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J Gastroenterol Hepatol 19(7):778-84 (Pubitemid 38981400)
21. Langar H, Triki H, Gouider E, et al (2005) Infections par des virus transmissibles par le sang chez des hémophiles en Tunisie. Transfus Clin Biol 12(4):301-5 (Epub 2005 Aug 11) (Pubitemid 41400244)
22. Laub R, Strengers P (2002) Parvoviruses and blood products. Pathol Biol 50(5):339-48 (Pubitemid 34680096)
23. Letaïef M, Vanham G, Boukef K, et al (1997) Higher prevalence of parvovirus B19 in Belgian as compared to Tunisian blood donors: differential implications for prevention of transfusional transmission. Transfus Sci 18(4):523-30
24. Loua A, Sow EM, Magassouba FB, et al (2004) Évaluation du risque infectieux résiduel chez les donneurs de sang au Centre national de transfusion sanguine de Conakry. Transfus Clin Biol 11(2):98-100 (Pubitemid 38561188)
25. Matsubayashi K, Nagaoka Y, Sakata H, et al (2004) Transfusiontransmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion 44(6):934-40 (Pubitemid 38738426)
26. Nicand E, Bigaillon C, Tessé S (2009) Hépatite E : maladie émergente ? 57(2):203-11 (Epub 2008 Jun 6)
27. Ocak S, Kaya H, Cetin M (2006) Seroprevalence of hepatitis B and hepatitis C in patients with thalassemia and sickle cell anemia in a long-term follow-up. Arch Med Res 37(7):895-8 (Pubitemid 44333149)
28. Rezig D, Ouneissa R, Mhiri L, et al (2008) Séroprévalences des infections aux hépatites A et E en Tunisie. Pathol Biol (Paris) 56 (3):148-53 (Epub 2008 Feb 21)
29. Touré-Fall AO, Dièye TN, Sall A, et al (2009) Risque résiduel de transmission du VIH et du VHB par transfusion sanguine entre 2003 et 2005 au Centre national de transfusion sanguine de Dakar (Sénégal). Transfus Clin Biol 16(5-6):439-43
30. Triki H, Said N, Ben Salah A, et al (1997) Seroepidemiology of hepatitis B, C and delta viruses in Tunisia. Trans R Soc Trop Med Hyg 91(1):11-4 (Pubitemid 27095488)